enVVeno Medical Corporation

NASDAQ:NVNO

5 (USD) • At close June 21, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Revenue 00.8240000000000000000000.0310.030.0420.0830.0310.1750.0280.0390.180.3050.295
Cost of Revenue 0.1410.1340.1380.1380.1360.130.1330.133000000000000000000.0980.13300.1890.2120.397
Gross Profit -0.1410.69-0.138-0.138-0.136-0.13-0.133-0.1330000000000000.0310.030.0420.0830.0310.077-0.1050.039-0.0080.093-0.101
Gross Profit Ratio 00.837000000000000000000111110.44-3.7681-0.0470.305-0.343
Reseach & Development Expenses 3.0522.9812.7984.2143.5952.7972.4923.0731.5521.7821.2251.091.6322.2770.7580.7060.5110.7880.6770.4280.3130.2930.4250.280.240.3490.0430.1850.07300
General & Administrative Expenses 0000000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000
SG&A 2.313.1632.5512.63.2023.6633.6593.9133.7837.2111.4821.2961.1761.8811.1640.840.9980.9221.1571.5321.3011.2171.1052.9151.2471.6571.6641.0861.051.2280.959
Other Expenses 000000000000.0010.032000000000000000000
Operating Expenses 5.3626.1445.3496.8146.7976.466.1516.9865.3358.9922.7072.3852.8084.1581.9221.5461.5091.711.8341.961.6141.511.5293.1951.4882.0061.7071.2711.1221.2280.959
Operating Income -5.503-6.278-5.349-6.814-6.797-6.46-6.151-6.986-5.335-8.992-2.707-2.385-2.808-4.158-1.922-1.546-1.509-2.299-1.834-1.96-1.582-1.799-1.488-3.112-1.456-1.929-1.812-1.232-1.131-1.136-1.06
Operating Income Ratio 0-7.619000000000000000000-50.646-59.055-35.708-37.328-46.884-11.013-64.999-31.746-6.271-3.725-3.588
Total Other Income Expenses Net 0.5110.6290.3040.3010.4050.280.054-0.1130.0050.0050.3130.0010.032-0.216-0.053-0.0810.3460.0080.0190.0140.009-0.320.0190.1841.4890.6240.0040.022-0.024-0.397-0.002
Income Before Tax -4.992-5.649-5.001-6.474-6.392-6.18-6.097-7.062-5.33-8.988-2.389-2.378-2.773-4.374-1.975-1.627-1.16-2.291-1.815-1.946-1.574-1.782-1.468-5.045-4.747-3.124-2.255-1.249-1.164-1.54-1.076
Income Before Tax Ratio 0-6.856000000000000000000-50.371-58.487-35.24-60.523-152.824-17.839-80.878-32.188-6.454-5.052-3.643
Income Tax Expense 01.453-0.348-0.34-0.765-0.474-0.0330.07600-0.317-0.007-0.003-00.0520.081-0.0030.5970.0190.0140.009-0.01700.1120.210.1090.4470.0160.0090.0070.014
Net Income -4.992-5.649-5.001-6.474-5.627-5.706-6.064-7.062-5.33-8.988-2.389-2.378-2.773-4.374-1.975-1.627-1.16-2.291-1.815-1.946-1.574-1.782-1.468-5.045-4.747-3.124-2.255-1.249-1.164-1.54-1.076
Net Income Ratio 0-6.856000000000000000000-50.371-58.487-35.24-60.523-152.824-17.839-80.878-32.188-6.454-5.052-3.643
EPS -0.31-0.42-0.45-0.58-0.5-0.6-0.54-0.63-0.47-0.8-0.26-0.28-0.48-1.72-1.37-1.89-1.57-3.19-2.53-3.28-3.21-3.79-3.13-16.21-11.69-8.06-5.82-2.85-2.65-3.51-2.45
EPS Diluted -0.31-0.42-0.45-0.58-0.5-0.6-0.54-0.63-0.47-0.8-0.26-0.28-0.48-1.72-1.37-1.89-1.57-3.19-2.53-3.28-3.21-3.79-3.13-16.21-11.69-8.06-5.82-2.85-2.65-3.51-2.45
EBITDA -5.362-6.144-5.515-6.977-7.021-6.566-5.997-6.74-5.206-8.871-2.899-2.278-2.705-4.062-1.771-1.361-1.422-1.597-1.711-1.85-1.482-1.446-1.454-5.084-5.993-3.606-1.779-1.219-1.094-1.095-1.02
EBITDA Ratio 0-7.456000000000000000000-47.447-47.458-34.906-60.987-192.918-20.589-63.814-31.423-6.067-3.591-3.451